SEC Form 4 · accession 0001104659-16-140009
Jaguar Health, Inc. · JAGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Roger J. Waltzman
Officer — Chief Scientific Officer
Period of report
Aug 12, 2016
Accepted (ET)
Aug 16, 2016 · 2:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001585608
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1,F2 | $1.47 | Aug 12, 2016 | A | 127,500 | A | — | Aug 12, 2026 | Common Stock | 127,500 | 127,500 | D |
Explanation of responses
- F1Granted pursuant to the Issuer's 2014 Equity Incentive Plan
- F2The option became exercisable as to 2/36th of the shares on July 1, 2016, the vesting commencement date (date of hire), then 7/36th of the shares vest nine months after the vesting commencement date, and the remaining shares vest at a rate of 1/36th of the total number of shares subject to the award for each month of continuous service thereafter. Vesting is subject to the Reporting Person's continued employment with the Issuer through the applicable vesting dates.